CSIMarket
 


Viridian Therapeutics Inc   (VRDN)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Viridian Therapeutics Inc 's Total Debt to Equity

VRDN's quarterly Total Debt to Equity and Total Debt, Equity growth


Despite a net increase in borrowings by 1.02%, Viridian Therapeutics Inc managed to enhance Total Debt to Equity in the forth quarter 2023 to 0.05, falling below the company's typical Total Debt to Equity.

Within Medical Laboratories industry Viridian Therapeutics Inc achieved the lowest Total Debt to Equity in the forth quarter 2023. While Total Debt to Equity total ranking has improved so far in the forth quarter 2023 to 109, from total ranking in the third quarter 2023 at 307 .

Explain Debt to Equity Ratio?
What is the structure of VRDN´s Total Debt?
How valuable is the VRDN´s Equity?


VRDN Total Debt to Equity (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change 11.89 % -30.67 % 122.59 % 110.36 % 110.46 %
Y / Y Total Debt Change 334.98 % 333.56 % 2.7 % - -
Total Debt to Equity MRQ 0.05 0.07 0.01 0.01 0.01
VRDN's Total Ranking # 109 # 307 # 52 # 130 # 101
Seq. Equity Change 55.87 % -10.22 % -9.9 % -11.27 % -3.41 %
Seq. Total Debt Change 1.02 % 324.72 % 0.68 % 0.69 % 0.69 %



Total Debt to Equity forth quarter 2023 Company Ranking
Within: No.
Medical Laboratories Industry # 1
Healthcare Sector # 14
Overall Market # 109


Total Debt to Equity Statistics
High Average Low
0.26 0.08 0
(Dec 31 2017)   (Jun 30 2014)




Financial Statements
Viridian Therapeutics Inc 's Equity $ 442 Millions Visit VRDN's Balance sheet
Viridian Therapeutics Inc 's Total Debt $ 20 Millions Visit VRDN's Balance sheet
Source of VRDN's Sales Visit VRDN's Sales by Geography


Cumulative Viridian Therapeutics Inc 's Total Debt to Equity

VRDN's Total Debt to Equity for the trailling 12 Months

VRDN Total Debt to Equity

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth 11.89 % -30.67 % 122.59 % 110.36 % 110.46 %
Y / Y Total Debt TTM Growth 334.98 % 333.56 % 2.7 % - -
Total Debt to Equity TTM 0.04 0.03 0.01 0.01 0.01
Total Ranking TTM # 148 # 11 # 9 # 161 # 4
Seq. Equity TTM Growth 55.87 % -10.22 % -9.9 % -11.27 % -3.41 %
Seq. Total Debt TTM Growth 1.02 % 324.72 % 0.68 % 0.69 % 0.69 %


On the trailing twelve months basis Due to the net new borrowings of 1.02% during the trailing twelve months finishing in the IV Quarter 2023, cumulativeTotal Debt to Equity improved to 0.04, above the Viridian Therapeutics Inc 's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Medical Laboratories industry VRDN recorded the lowest Total Debt to Equity. While Total Debt to Equity total ranking has deteriorated during the twelve months ending in the IV Quarter 2023, compared to the prior period, from 11 to 148.

Explain Debt to Equity Ratio?
What is the structure of VRDN´s Total Debt?
How valuable is the VRDN´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Medical Laboratories Industry # 1
Healthcare Sector # 27
Within the Market # 148


trailing twelve months Total Debt to Equity Statistics
High Average Low
0.11 0.03 0.01
(Dec 31 2020)   (Jun 30 2022)




Companies with similar Total Debt to Equity in the quarter ending Dec 31 2023, within Medical Laboratories Industry Total Debt to EquityDec 31 2023 MRQ Total DebtDec 31 2023 MRQ Equity
Enzo Biochem Inc  0.05 $ 3.459  Millions$ 70.775  Millions
Viridian Therapeutics Inc   0.05 $ 20.205  Millions$ 442.022  Millions
Absci Corp  0.04 $ 7.918  Millions$ 176.176  Millions

Date modified: 2024-02-28T15:01:25+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com